Although these medications dont typically produce the rapid 1520% average weight loss seen with GLP-1s, they can still lead to clinically meaningful reductions of about 510% of body weight, which can improve blood pressure, blood sugar, and cholesterol levels
Finally, the lack of detailed reasons for redialysis or mortality also constrains the depth of our outcome analysis, In summary, our observations suggest that GLP-1 RAs may be associated with a reduction in the risk of mortality, MACEs, and MAKEs in patients with type 2 diabetes following severe AKI, over a median follow-up of 2.3 years
Diabetologia 48(4):675686
Ghotbizadeh Vahdani F et al
The Right Exercise Protocol During a Plateau Exercise is the single most powerful non-pharmacological intervention for a GLP-1 plateau but the type of exercise matters enormously
Sleep optimization deserves attention given the bodys tissue repair processes concentrate during deep sleep phases